Methods to assess the economic outcomes of clinical pharmacy services

Pharmacotherapy

Volumn 20, Issue 10 II, 2000, Pages

  Schumock, G T ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL PHARMACY; CLINICAL RESEARCH; CONFERENCE PAPER; COST BENEFIT ANALYSIS; DRUG COST; DRUG MISUSE; ECONOMICS; EVALUATION; HEALTH CARE FINANCING; HEALTH CARE MANAGEMENT; HEALTH CARE QUALITY; MORTALITY; OUTCOMES RESEARCH; QUALITY CONTROL; UNITED STATES;

EID: 0033786437     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.20.16.243s.35018     Document Type: Conference Paper

References (33)

1. Incidence of adverse events and negligence in hospitalized patients: Results of the Harvard Medical Practice Study. I
2. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II
3. Drug related problems: Their structure and function
4. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies
5. Increase in US medication-error deaths between 1983 and 1993
6. Drug related morbidity and mortality. A cost-of-illness model
7. The health care cost of drug-related morbidity and mortality in nursing facilities
8. The costs of adverse drug events in hospitalized patients
9. Health care professional staffing, hospital characteristics, and hospital mortality rates
10. Clinical pharmacy services and hospital mortality rates
11. 1995 National clinical pharmacy services study
12. Economic evaluations of clinical pharmacy services - 1988-1995. The Publications Committee of the American College of Clinical Pharmacy
13. Need to develop a legal and ethical base for pharmaceutical care
14. Opportunities and responsibilities in pharmaceutical care
15. Clinical economics: A guide to the economic analysis of clinical practices
16. Individualizing gentamicin dosage regimens in burn patients with gram-negative septicemia: A cost-benefit analysis
17. An eleven-year review of the pharmacy literature: Documentation of the value and acceptance of clinical pharmacy
18. A 32-year literature review on the value and acceptance of ambulatory care provided by pharmacists
19. Prospectus on the economic value of clinical pharmacy services
20. Reengineering: An opportunity to advance clinical practice in a community hospital
21. Cost-effectiveness of consultant pharmacists in managing drug-related morbidity and mortality at nursing facilities
22. Benefit analysis of pharmaceutical care in a medicaid population - From a budgetary perspective
23. Impact of pharmacist consultation provided to patients with diabetes on healthcare costs in a health maintenance organization
24. The cost-effectiveness of clinical pharmacist intervention among elderly outpatients
25. Economic evaluation of pharmacist involvement in disease management in a community pharmacy setting
26. Pharmaceutical care in medical progressive care patients
27. Cost savings and avoidance from clinical interventions
28. Cost impact and clinical benefits of focused rounding in the cardiovascular intensive care unit
29. Guidelines for performing a pharmacoeconomic analysis
30. Pharmacoeconomics and the evaluation of drugs and services
31. Some techniques for adapting pharmacoeconomics and outcomes research to pharmaceutical care